Faisal S. Ali - Concepedia

Author

Faisal S. Ali

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

F Ali, F Shaukat Ali, F. Ali, F. S. Ali, Faisal Ali, Faisal S Ali, Faisal S. Ali, Faisal Shaukat Ali, Faisal Shaukat S Ali, Fida Ali

229

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center The University of Texas Health Science Center at Houston Baylor College of Medicine Presence Saint Joseph Hospital Saint Joseph Hospital

About

Faisal S. Ali is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	218
2	Immunology	3	3	153
3	Gastroenterology	2	2	43
4	Health Sciences	1	1	22
5	Diabetes	1	1	14

Faisal S. Ali

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study Hamzah Abu‐Sbeih, Faisal S. Ali, Dana Alsaadi, Journal for ImmunoTherapy of Cancer	2018	206
Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis Hamzah Abu‐Sbeih, Faisal S. Ali, Wenyi Luo, Journal for ImmunoTherapy of Cancer	2018	203
Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis Hamzah Abu‐Sbeih, Faisal S. Ali, Abdul Rafeh Naqash, Journal of Clinical Oncology	2019	192
Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor–induced colitis Hamzah Abu‐Sbeih, Faisal S. Ali, Xuemei Wang, Journal for ImmunoTherapy of Cancer	2019	188
Immune checkpoint inhibitor-induced colitis as a predictor of survival in metastatic melanoma Hamzah Abu‐Sbeih, Faisal S. Ali, Wei Qiao, Cancer Immunology Immunotherapy InflammationImmune EvasionCancer ImmunosurveillanceMedicineMelanoma	2019	87
The Impact of Immune Checkpoint Inhibitor-Related Adverse Events and Their Immunosuppressive Treatment on Patients’ Outcomes Hamzah Abu‐Sbeih, Tenglong Tang, Faisal S. Ali, Journal of Immunotherapy and Precision Oncology Steroid TreatmentImmunodeficienciesCancer ManagementImmunologyImmunotherapeutics	2018	52
Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell Therapy Hamzah Abu‐Sbeih, Tenglong Tang, Faisal S. Ali, American Journal of Clinical Oncology	2019	30
Safety and efficacy of metal stents for malignant colonic obstruction in patients treated with bevacizumab Jeffrey H. Lee, Ikenna K. Emelogu, Keshav Kukreja, Gastrointestinal Endoscopy MedicineGastroenterologyColorectal CancerLumen-apposing Metal StentVisceral Surgery	2019	29
Major Stressful Life Events and Risk of Developing Lung Cancer: A Case-Control Study Syed Hasan Raza Jafri, Faisal S. Ali, Arash Mollaeian, Clinical Medicine Insights Oncology	2019	23
Safety of endoscopy in cancer patients with thrombocytopenia and neutropenia Hamzah Abu‐Sbeih, Faisal S. Ali, Emmanuel Coronel, Gastrointestinal Endoscopy ThrombosisVenous ThrombosisMedicineHematologySurgery	2018	22

Page 1